Print

AVEG 014C

Trial Details:

I Completed
National Institute of Allergy and Infectious Diseases (NIAID) June 07, 1993
TBC-3B,MN rgp120 Vaccinia env and gag/pol IIIB; Env gp120 B
TBC-3B Viral Vector - Pox
MN rgp120 Protein
USA 36
NCT00000866
https://clinicaltrials.gov/show/NCT00000866